UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 203.50
+1.70 (0.84%)
Oct 9, 2026, 5:35 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €38.8 billion as of October 9, 2026. It is the 572nd most valuable company in the world and the 4th biggest in Belgium. Its market cap has decreased by 20.42% in one year.
Market Cap
38.80B
Enterprise Value
41.62B
Revenue
8.52B
Global Rank
Country Rank
#4 Belgium
PE Ratio
17.98
ChartMarket Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 38.80B, an increase of 4,256.27%. That is a compound annual growth rate of 12.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 38.80B | -14.41% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 45.55B |
| Financière de Tubize | 7.57B |
| Onward Medical | 171.74M |
| Hyloris Pharmaceuticals | 104.16M |
| European Medical Solutions | 16.50M |
| Celyad Oncology | 8.95M |
| BioSenic | 1.31M |
| Oxurion NV | 168.88K |